Presum Pharma Private Limited
About Presum Pharma Private Limited
Data last updated:
Presum Pharma Private Limited is a private limited company based in Katihar, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 September 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24233BR2013PTC021091. Its GSTIN is 10AAHCP4203C1ZA (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.5 Lakh. It is led by directors Sumit Sukant and Preet Prashank.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Dr Sudhir Kumar Sinha Gami Tola Opposite Madarsa, Katihar, Bihar, India – 854105.
As per the financials filed for FY 2024, the company reported a revenue of ₹75.64 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹2.41 Lakh (net margin 3.2%) and EBITDA of ₹3.28 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Presum Pharma Private Limited's registered office is in Katihar, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Dr Sudhir Kumar Sinha Gami Tola Opposite Madarsa, Katihar, Bihar, India – 854105
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Presum Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Presum Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Presum Pharma Private Limited, buy the company report.
Financials of Presum Pharma Private Limited
FY 2025 filings availablePresum Pharma Private Limited reported revenue of ₹75.64 Lakh (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over three years, including 7% growth in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Presum Pharma Private Limited, buy the company report.
Board of directors of Presum Pharma Private Limited
Presum Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Sukant | Director | 04 Sep 2013 | 13 Years 1 Months | Current |
| Preet Prashank | Director | 04 Sep 2013 | 13 Years 1 Months | Current |
Peer comparison
Presum Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Auronext Pharma Private Limited | ₹75.75 Lakh (FY 2023) | 23.0% | Hyderabad, Telangana, India | |||
| Bharavi Pharmaceuticals Limited | ₹75.7 Lakh (FY 2024) | 2.0% | Vadodara, Gujarat, India | |||
| Presum Pharma Private Limitedthis company | ₹75.64 Lakh (FY 2024) | ₹2.41 Lakh | 3.2% | 7.0% | Katihar, Bihar, India | |
| Aarya Lifesciences Private Limited | ₹75.62 Lakh (FY 2025) | -45.0% | Ahmedabad, Gujarat, India | |||
| Wecare Formulations Private Limited | ₹75.51 Lakh (FY 2024) | -39.0% | Delhi, India | |||
| S.P. Biotech Private Limited | ₹75.48 Lakh (FY 2025) | 13.0% | Uttar Pradesh, India |
To see the full peer comparison of Presum Pharma Private Limited, buy the company report.
Auditor
Presum Pharma Private Limited is audited by AJAY CHANDESHWARI PRASAD & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJAY CHANDESHWARI PRASAD & CO | FY 2021 | 010232C |
Shareholding
The shareholding of Presum Pharma Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Presum Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Presum Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Presum Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Presum Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAHCP4203C1ZA | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Presum Pharma Private Limited, buy the company report.
Recent activity
Presum Pharma Private Limited has 2 board changes on record since 2013: 2 appointments. The latest: Preet Prashank was appointed as Director on 04 Sep 2013.
Frequently asked questions
Presum Pharma is an active private limited company based in Katihar, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 September 2013 (13+ years old) and is registered under CIN U24233BR2013PTC021091.
Presum Pharma has 2 current directors:
- Sumit Sukant - Director
- Preet Prashank - Director
The latest financial statements of Presum Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Presum Pharma is 10AAHCP4203C1ZA, registered in Bihar.
The CIN (Corporate Identification Number) of Presum Pharma is U24233BR2013PTC021091. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Presum Pharma was incorporated on 04 September 2013, making it 13+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Presum Pharma by revenue are Auronext Pharma Private Limited, Bharavi Pharmaceuticals Limited, Aarya Lifesciences Private Limited, Wecare Formulations Private Limited, S.P. Biotech Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Preet Prashank was appointed as Director on 04 Sep 2013. Sumit Sukant was appointed as Director on 04 Sep 2013.
The registered office of Presum Pharma is at CO Dr Sudhir Kumar Sinha Gami Tola Opposite Madarsa, Katihar, Bihar, India – 854105.
Presum Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Presum Pharma is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
